OXGENE—founded in 2011 as Oxford Genetics Ltd. and re-branded in 2019—will continue operations under its own name as a wholly-owned subsidiary of WuXi AppTec’s cell and gene therapy business unit . . .
The post OXGENE Eyes Further Growth in Cell and Gene Therapy Services after Acquisition by WuXi AppTec appeared first on GEN – Genetic Engineering and Biotechnology News.
